摘要
可逆的组蛋白乙酰化是一个著名的基因表达的表观遗传调控机制。最近,有研究表明,在几种蛋白中的乙酰化/脱乙酰化调节细胞活动的多个方面,特别是那些与能量代谢有关的。血小板在止血和心血管疾病中起关键作用。虽然代谢变化,如糖尿病或血脂是公认的心血管疾病危险因素,但是有代谢和血小板反应性之间的关系的信息很少。最近的研究报告表明,血小板功能的不同方面,如粘附,聚集,或颗粒释放,也可以通过调节蛋白质的乙酰化。这些循环的乙酰化/去乙酰化酶和去乙酰化酶的对比作用的调节,他们分别在血小板被描述成为P300,HDAC6和乙酰化酶的存在。值得注意的是,去乙酰化酶,特别是乙酰化酶由于其蕴涵在多种生理和病理过程在生物学科产生了密集的药学研究。血小板中的乙酰化机制的发现为通过乙酰基转移酶/脱乙酰酶血小板调节心血管疾病的预防和治疗开辟了新的可能性。因此,这篇综述的目的是提出一些最近关于乙酰化的蛋白质在控制血小板功能的作用的报告和其代表的血小板功能调节新的可能性。
关键词: 乙酰化,血小板,心血管疾病,阿司匹林,癌症,乙酰化酶。
Current Medicinal Chemistry
Title:Regulation of Platelet Function by Acetylation/Deacetylation Mechanisms
Volume: 23 Issue: 35
Author(s): Ana Latorre and Antonio Moscardó
Affiliation:
关键词: 乙酰化,血小板,心血管疾病,阿司匹林,癌症,乙酰化酶。
摘要: Reversible acetylation of histones is a well-known mechanism of epigenetic regulation of gene expression. More recently, studies have demonstrated that acetylation/deacetylation in several proteins regulate multiple aspects of cellular activity, especially those associated with energetic metabolism. Platelets are key participants in haemostasis and cardiovascular diseases. Although metabolic changes such as diabetes or lipidemia are well recognized risk factors for cardiovascular diseases, there is very little information about the relationship between metabolism and platelet reactivity. Recent studies have reported that different aspects of platelet function such as adhesion, aggregation, or granule release could also be regulated by acetylation of proteins. These cycles of acetylation/deacetylation are regulated by the contrasting action of acetyltransferases and deacetylases, which have been described by the presence of p300 and HDAC6, and sirtuins, respectively, in platelets. Remarkably, deacetylases, especially sirtuins, have been the subjects of intensive pharmaceutical research due to their implication in several physiological and pathological processes in organisms. The discovery of acetylation mechanisms in platelets opens new possibilities for the treatment and prevention of cardiovascular diseases through the regulation of acetylases/deacetylases in platelets. Therefore, the aim of this review is to present some recent reports concerning the role of acetylation of proteins in the control of platelet function, and the new possibilities of regulation of platelet function that this represent.
Export Options
About this article
Cite this article as:
Ana Latorre and Antonio Moscardó , Regulation of Platelet Function by Acetylation/Deacetylation Mechanisms, Current Medicinal Chemistry 2016; 23 (35) . https://dx.doi.org/10.2174/0929867323666160907112038
DOI https://dx.doi.org/10.2174/0929867323666160907112038 |
Print ISSN 0929-8673 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-533X |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Recent Advances on the Antiatherogenic Effects of HDL-Derived Proteins and Mimetic Peptides
Current Pharmaceutical Design C-reactive Protein, Infection, and Outcome After Acute Ischemic Stroke: A Registry and Systematic Review
Current Neurovascular Research Future of Cardiac Pacemaker – an Update of Biological Pacemaker Patents
Recent Patents on Biomedical Engineering (Discontinued) Pulmonary Arterial Hypertension: Need to Treat
Inflammation & Allergy - Drug Targets (Discontinued) Could Resveratrol be a Useful Drug for the Treatment of Malignant Hemopathies?
Recent Patents on Anti-Cancer Drug Discovery Strategies for Effective Naked-DNA Vaccination Against Infectious Diseases
Recent Patents on Anti-Infective Drug Discovery Subject Index to Volume 2
Current Vascular Pharmacology Averrhoa bilimbi L. leaf Aqueous Extract Modulates both Cardiac Contractility and Frequency in the Guinea-pig Atrium by the Activation of Muscarinic Receptors
Letters in Drug Design & Discovery Editorial [Hot Topic Biomarkers, Molecular Imaging, and Novel Therapies of Cancer]
Current Molecular Medicine The Potential Role of Antioxidants in Metabolic Syndrome
Current Pharmaceutical Design Sudden Unexpected Death in Infancy and the Dilemma of Defining the Sudden Infant Death Syndrome
Current Pediatric Reviews New Insights into HLA-G and Inflammatory Diseases
Inflammation & Allergy - Drug Targets (Discontinued) Torasemide for the Treatment of Heart Failure
Cardiovascular & Hematological Disorders-Drug Targets The Application of Mass Spectrometry to Proteomics and Metabolomics in Biomarker Discovery and Drug Development
Current Molecular Pharmacology Phosphodiesterase 5 Inhibitors in the Treatment of Erectile Dysfunction
Current Pharmaceutical Design Antiplatelet Agents in Cardiology: A Report on Aspirin, Clopidogrel, Prasugrel, and Ticagrelor
Current Pharmaceutical Design (Iso)Flav(an)ones, Chalcones, Catechins, and Theaflavins as Anticarcinogens: Mechanisms, Anti-Multidrug Resistance and QSAR Studies
Current Medicinal Chemistry Cardioprotective Effects of Natural Products <i>via</i> the Nrf2 Signaling Pathway
Current Vascular Pharmacology Insulin Resistance as a Therapeutic Target for Improved Endothelial Function:Metformin
Current Drug Targets - Cardiovascular & Hematological Disorders Improving Red Blood Cell K-Uptake and its Impact on O2/CO2 Exchange, and NO-Generation in Microvascular CHD: A Novel Therapeutic Approach
Recent Patents on Cardiovascular Drug Discovery